Literature DB >> 15664513

Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.

Youngseon Choi1, Thommey Thomas, Alina Kotlyar, Mohammad T Islam, James R Baker.   

Abstract

We sought to produce dendrimers conjugated to different biofunctional moieties (fluorescein [FITC] and folic acid [FA]), and then link them together using complementary DNA oligonucleotides to produce clustered molecules that target cancer cells that overexpress the high-affinity folate receptor. Amine-terminated, generation 5 polyamidoamine (G5 PAMAM) dendrimers are first partially acetylated and then conjugated with FITC or FA, followed by the covalent attachment of complementary, 5'-phosphate-modified 34-base-long oligonucleotides. Hybridization of these oligonucleotide conjugates led to the self-assembly of the FITC- and FA-conjugated dendrimers. In vitro studies of the DNA-linked dendrimer clusters indicated specific binding to KB cells expressing the folate receptor. Confocal microscopy also showed the internalization of the dendrimer cluster. These results demonstrate the ability to design and produce supramolecular arrays of dendrimers using oligonucleotide bridges. This will also allow for further development of DNA-linked dendrimer clusters as imaging agents and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664513     DOI: 10.1016/j.chembiol.2004.10.016

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  31 in total

1.  PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

Authors:  Fereydoon Abedi-Gaballu; Gholamreza Dehghan; Maryam Ghaffari; Reza Yekta; Soheil Abbaspour-Ravasjani; Behzad Baradaran; Jafar Ezzati Nazhad Dolatabadi; Michael R Hamblin
Journal:  Appl Mater Today       Date:  2018-05-29

2.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

3.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

4.  Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Authors:  Douglas G Mullen; Daniel Q McNerny; Ankur Desai; Xue-Min Cheng; Stassi C Dimaggio; Alina Kotlyar; Yueyang Zhong; Suyang Qin; Christopher V Kelly; Thommey P Thomas; Istvan Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2011-03-22       Impact factor: 4.774

Review 5.  RNA interference and antiviral therapy.

Authors:  Yan Ma; Chu-Yan Chan; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

6.  Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery.

Authors:  Sandra Kraljevic; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

Review 7.  Combinatorial and rational approaches to polymer synthesis for medicine.

Authors:  Michael Goldberg; Kerry Mahon; Daniel Anderson
Journal:  Adv Drug Deliv Rev       Date:  2008-03-04       Impact factor: 15.470

8.  Nanotechnology of emerging targeting systems.

Authors:  S S Smith
Journal:  Minerva Biotecnol       Date:  2008-09       Impact factor: 3.028

9.  Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells.

Authors:  Bijesh K Biswal; Manniledam Kavitha; R S Verma; Edamana Prasad
Journal:  Cytotechnology       Date:  2009-11-12       Impact factor: 2.058

10.  Multiscale modeling of dendrimers and their interactions with bilayers and polyelectrolytes.

Authors:  Hwankyu Lee; Ronald G Larson
Journal:  Molecules       Date:  2009-01-19       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.